title: Balancing the risk of complications in foot and ankle surgical patients taking antithrombotic medication.
abstract: This review intends to provide guidance regarding perioperative management of anticoagulation and antiplatelet drug therapy as they relate to foot and ankle surgery. Venous and arterial thromboembolism are conditions in which the blood clots inappropriately, causing considerable morbidity and mortality. With an increase in awareness of thromboembolic risk factors and expansion of therapeutic options, more patients are routinely taking antithrombotic medication. When these patients require invasive procedures, a decision needs to be made if antithrombotic medication should be held perioperatively and if additional precautions are needed in the interim. Understanding the factors affecting the management of thromboembolism during the perioperative period can reduce the potential for complications.
  
  
  METHODS
  Therapeutic, Level V: Expert opinion.
authors: Skokie Foot & Ankle Specialists, Skokie, Illinois (SM)Thrombosis and Anticoagulation Unit of Glenbrook Hospital, NorthShore University HealthSystem, Glenview, Illinois (DNG)Division of Vascular Surgery, NorthShore University HealthSystem, Evanston, Illinois (JAC) miller613@hotmail.com.
authors: Steven
authors: S
authors: Miller
authors: Skokie Foot & Ankle Specialists, Skokie, Illinois (SM)Thrombosis and Anticoagulation Unit of Glenbrook Hospital, NorthShore University HealthSystem, Glenview, Illinois (DNG)Division of Vascular Surgery, NorthShore University HealthSystem, Evanston, Illinois (JAC).
authors: Diane
authors: D
authors: Nitzki-George
authors: Skokie Foot & Ankle Specialists, Skokie, Illinois (SM)Thrombosis and Anticoagulation Unit of Glenbrook Hospital, NorthShore University HealthSystem, Glenview, Illinois (DNG)Division of Vascular Surgery, NorthShore University HealthSystem, Evanston, Illinois (JAC).
authors: Joseph A
authors: JA
authors: Caprini
mesh_terms: D016512:Ankle Injuries / Q000601:surgery*; D000925:Anticoagulants / Q000627:therapeutic use*; D000991:Antithrombins / Q000494:pharmacology / Q000627:therapeutic use; D001777:Blood Coagulation / Q000502:physiology; D065427:Factor Xa Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D018409:Foot Injuries / Q000601:surgery*; D006801:Humans; D019637:Orthopedic Procedures; D019990:Perioperative Care; D015539:Platelet Activation / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D018570:Risk Assessment; D013923:Thromboembolism / Q000503:physiopathology / Q000517:prevention & control; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014812:Vitamin K
keywords: anticoagulant; antiplatelet; antithrombotic; blood thinner; surgery